Cohen & Steers’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$552K Buy
600
+60
+11% +$60.8K ﹤0.01% 297
2025
Q4
$580K Hold
540
﹤0.01% 295
2025
Q3
$412K Hold
540
﹤0.01% 309
2025
Q2
$421K Hold
540
﹤0.01% 302
2025
Q1
$446K Sell
540
-156
-22% -$130K ﹤0.01% 288
2024
Q4
$537K Buy
696
+218
+46% +$181K ﹤0.01% 284
2024
Q3
$423K Buy
478
+9
+2% +$8.09K ﹤0.01% 290
2024
Q2
$425K Sell
469
-8
-2% -$6.4K ﹤0.01% 285
2024
Q1
$371K Hold
477
﹤0.01% 301
2023
Q4
$278K Hold
477
﹤0.01% 321
2023
Q3
$256K Buy
+477
New +$246K ﹤0.01% 303

Other funds holding LLY

Cohen & Steers's LLY Position: Q1 2026 in Review

Cohen & Steers increased its Eli Lilly (LLY) stake by 11% in Q1 2026, buying an estimated $60.8K and bringing the position to 600 shares worth $552K. The position accounts for ﹤0.01% of the portfolio, ranked #297.

Cohen & Steers first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. The position peaked at $580K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Cohen & Steers held 600 shares of Eli Lilly worth $552K as of Q1 2026.
  • Cohen & Steers bought 60 Eli Lilly shares in Q1 2026, an estimated $60.8K.
  • Eli Lilly made up ﹤0.01% of Cohen & Steers's portfolio in Q1 2026, its #297 holding.
  • Cohen & Steers first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
  • Cohen & Steers's Eli Lilly position peaked at $580K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Cohen & Steers's 13F filing for Q1 2026, filed 15 May 2026.